Back to Companies
Cullinan Therapeutics, Inc.
CGEMNasdaqCIK: 0001789972
Cullinan Therapeutics, Inc. (CGEM) shows 23 recent insider filings from 12 insiders, with 1 buying and 4 selling. With $13.3M in purchases and $433.1K in sales, the recent tape is heavily weighted toward buying (a net purchase of $12.9M). Lynx1 Capital Management LP (10% Owner) is the most active by dollar volume, and the single largest transaction was $9.8M by Lynx1 Capital Management LP. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$16.9M
Purchases
$13.3M
Sales
$433.1K
Unique Insiders
12
Recent Insider Trades
23 loaded
| Jul 7 | CGEM Cullinan Therapeutics, Inc. | Michaelson Jennifer | Insider | Sell | $142.6K |
| Jul 2 | CGEM Cullinan Therapeutics, Inc. | Fenton Mary Kay | Insider | Grant | $13.3K |
| Jul 2 | CGEM Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | Insider | Grant | $21.2K |
| Jun 18 | CGEM Cullinan Therapeutics, Inc. | Meek David D. | Insider | Award | $343.1K |
| Jun 18 | CGEM Cullinan Therapeutics, Inc. | Doyle Mittie | Insider | Award | $295.1K |
| Jun 18 | CGEM Cullinan Therapeutics, Inc. | Allen Andrew R | Insider | Award | $295.1K |
| Jun 18 | CGEM Cullinan Therapeutics, Inc. | Thistle Mary | Insider | Award | $343.1K |
| Jun 18 | CGEM Cullinan Therapeutics, Inc. | Webster Stephen W | Insider | Award | $343.1K |
| Jun 18 | CGEM Cullinan Therapeutics, Inc. | Rosenberg Anthony | Insider | Award | $343.1K |
| Feb 26 | CGEM Cullinan Therapeutics, Inc. | Michaelson Jennifer | Insider | Sell | $25.2K |
| Dec 29 | CGEM Cullinan Therapeutics, Inc. | AHMED NADIM | Insider | Sell | $99.3K |
| Dec 19 | CGEM Cullinan Therapeutics, Inc. | SUMER JACQUELYN L | Insider | Sell | $33.7K |
| Dec 19 | CGEM Cullinan Therapeutics, Inc. | Jones Jeffrey Alan | Insider | Sell | $44.8K |
| Dec 16 | CGEM Cullinan Therapeutics, Inc. | Michaelson Jennifer | Insider | Sell | $38.4K |
| Nov 25 | CGEM Cullinan Therapeutics, Inc. | Michaelson Jennifer | Insider | Sell | $49.2K |
| Oct 30 | CGEM Cullinan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% Owner | Buy | $1.4M |
| Oct 21 | CGEM Cullinan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% Owner | Buy | $2.1M |
| Oct 10 | CGEM Cullinan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% Owner | Buy | $9.8M |
| Oct 10 | CGEM Cullinan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% Owner | Other | $0 |
| Aug 8 | CGEM Cullinan Therapeutics, Inc. | Allen Andrew R | Insider | Award | $558.6K |
| Aug 8 | CGEM Cullinan Therapeutics, Inc. | Doyle Mittie | Insider | Other | $0 |
| Aug 8 | CGEM Cullinan Therapeutics, Inc. | Allen Andrew R | Insider | Other | $0 |
| Aug 8 | CGEM Cullinan Therapeutics, Inc. | Doyle Mittie | Insider | Award | $558.6K |
23 filings